High sensitivity troponin in the management of tachyarrhythmias
High sensitivity troponin in the management of tachyarrhythmias
Background: The introduction of the highly sensitive troponin (hs-trop) assays into clinical practice has allowed for the more rapid diagnosis or exclusion of type 1 myocardial infarctions (T1MI) by clinicians, in addition type 2 myocardial infarctions (T2MI) are now more frequently detected. Tachyarrhythmias are one of the common causes of T2MI, the medium and long term outcome for this cohort of T2MI is yet to be clarified.
Methods: Retrospective review of consecutive patients admitted with a diagnosis of either (a) non ST-elevation myocardial infarction (NSTEMI) or (b) tachyarrhythmia was performed. Data were collected on patient demographics and investigations. Patient mortality status was recorded through the Personal Demographics Service (PDS) via NHS Digital.
Results: A total of 704 patients were eligible for inclusion to the study. 264 patients were included in the study with a final discharge diagnosis of NSTEMI and 440 patients with a final discharge diagnosis of tachyarrhythmia. There was a significantly higher peak troponin in NSTEMI patients compared to the tachyarrhythmia troponin positive group (4552. ng/L vs 571. ng/L, p <. 0.001). Mortality was significantly higher in the troponin positive tachyarrhythmia patients than the troponin negative patients (54 vs 34, 26.2% vs 14.5%, log rank p = 0.003), furthermore, the mortality of NSTEMI and troponin positive tachyarrhythmia patients was similar (55 vs 54, 20.8% vs 26.2%, log rank p = 0.416). Only one patient (0.14%) was given a formal diagnosis of T2MI.
Conclusions: These data suggest that troponin positive tachyarrhythmia is not a benign diagnosis, and has a mortality rate similar to NSTEMI. Formal labeling as T2MI is rare in real life practice. More investigation into the detection and management of T2MI and troponin positive arrhythmia patients is now warranted.
Adult, Aged, Aged, 80 and over, Biomarkers/blood, Female, Humans, Male, Middle Aged, Non-ST Elevated Myocardial Infarction/blood, Predictive Value of Tests, Prognosis, Retrospective Studies, Risk Factors, Tachycardia/blood, Time Factors, Troponin/blood, Up-Regulation, Young Adult
487-492
Mariathas, Mark
e8dbbe0d-d303-41a4-a5a2-fa8900accfe6
Gemmell, Cameron
df8339e5-4f7e-45a8-b8cd-e27ed0aa0a2e
Olechowski, Bartosz
b025b40b-f9fa-4b8e-8f57-310d47e57700
Nicholas, Zoe
98403583-c418-45ad-836b-1831517dcc5f
Mahmoudi, Michael
f6a55246-399e-4f81-944e-a4b169786e8a
Curzen, Nick
c590bddc-f851-4b94-b3b8-00120e8a87ef
Curzen, Nicholas
70f3ea49-51b1-418f-8e56-8210aef1abf4
July 2018
Mariathas, Mark
e8dbbe0d-d303-41a4-a5a2-fa8900accfe6
Gemmell, Cameron
df8339e5-4f7e-45a8-b8cd-e27ed0aa0a2e
Olechowski, Bartosz
b025b40b-f9fa-4b8e-8f57-310d47e57700
Nicholas, Zoe
98403583-c418-45ad-836b-1831517dcc5f
Mahmoudi, Michael
f6a55246-399e-4f81-944e-a4b169786e8a
Curzen, Nick
c590bddc-f851-4b94-b3b8-00120e8a87ef
Curzen, Nicholas
70f3ea49-51b1-418f-8e56-8210aef1abf4
Mariathas, Mark, Gemmell, Cameron, Olechowski, Bartosz, Nicholas, Zoe, Mahmoudi, Michael, Curzen, Nick and Curzen, Nicholas
(2018)
High sensitivity troponin in the management of tachyarrhythmias.
Cardiovascular Revascularization Medicine, 19 (5 Pt A), .
(doi:10.1016/j.carrev.2017.11.011).
Abstract
Background: The introduction of the highly sensitive troponin (hs-trop) assays into clinical practice has allowed for the more rapid diagnosis or exclusion of type 1 myocardial infarctions (T1MI) by clinicians, in addition type 2 myocardial infarctions (T2MI) are now more frequently detected. Tachyarrhythmias are one of the common causes of T2MI, the medium and long term outcome for this cohort of T2MI is yet to be clarified.
Methods: Retrospective review of consecutive patients admitted with a diagnosis of either (a) non ST-elevation myocardial infarction (NSTEMI) or (b) tachyarrhythmia was performed. Data were collected on patient demographics and investigations. Patient mortality status was recorded through the Personal Demographics Service (PDS) via NHS Digital.
Results: A total of 704 patients were eligible for inclusion to the study. 264 patients were included in the study with a final discharge diagnosis of NSTEMI and 440 patients with a final discharge diagnosis of tachyarrhythmia. There was a significantly higher peak troponin in NSTEMI patients compared to the tachyarrhythmia troponin positive group (4552. ng/L vs 571. ng/L, p <. 0.001). Mortality was significantly higher in the troponin positive tachyarrhythmia patients than the troponin negative patients (54 vs 34, 26.2% vs 14.5%, log rank p = 0.003), furthermore, the mortality of NSTEMI and troponin positive tachyarrhythmia patients was similar (55 vs 54, 20.8% vs 26.2%, log rank p = 0.416). Only one patient (0.14%) was given a formal diagnosis of T2MI.
Conclusions: These data suggest that troponin positive tachyarrhythmia is not a benign diagnosis, and has a mortality rate similar to NSTEMI. Formal labeling as T2MI is rare in real life practice. More investigation into the detection and management of T2MI and troponin positive arrhythmia patients is now warranted.
This record has no associated files available for download.
More information
Accepted/In Press date: 21 November 2017
e-pub ahead of print date: 28 November 2017
Published date: July 2018
Keywords:
Adult, Aged, Aged, 80 and over, Biomarkers/blood, Female, Humans, Male, Middle Aged, Non-ST Elevated Myocardial Infarction/blood, Predictive Value of Tests, Prognosis, Retrospective Studies, Risk Factors, Tachycardia/blood, Time Factors, Troponin/blood, Up-Regulation, Young Adult
Identifiers
Local EPrints ID: 418307
URI: http://eprints.soton.ac.uk/id/eprint/418307
ISSN: 1553-8389
PURE UUID: 53ee0e50-d472-4935-97c0-25587c559f52
Catalogue record
Date deposited: 27 Feb 2018 17:31
Last modified: 16 Mar 2024 04:24
Export record
Altmetrics
Contributors
Author:
Mark Mariathas
Author:
Cameron Gemmell
Author:
Bartosz Olechowski
Author:
Zoe Nicholas
Author:
Nick Curzen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics